AMANTAPharmaceuticals
Amanta Healthcar — Quarterly Results & Earnings
₹99.81
+0.46%
Profit Growth YoY-17.26%Latest quarter
Sales Growth YoY6.23%Latest quarter
Sales CAGR 5Y8.30%5 year compound
Profit CAGR 5Y20.68%5 year compound
📋
Quarterly Performance
YoY Profit Growth-17.26%
🔴 Significant decline
YoY Sales Growth+6.23%
📈 Moderate growth
OPM 5Y Average
21.51%Operating profit margin
EPS Growth 5Y
20.32%Interest Coverage
1.53Higher = safer debt servicing
ROE
12.99%ROCE
14.80%💡
Growth Analysis
Amanta Healthcar reported YoY profit growth of -17.26% and revenue growth of 6.23% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 8.30% and profits at 20.68% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Amanta Healthcar
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.